Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sudeshna, Rakshit"'
Autor:
Arya Chatterjee, Arunangsu Singh, Geetha Shanmugam, Sudeshna Rakshit, Latika M Mohanty, Ashok Kumar, Sitaram Harihar, Koustav Sarkar
Publikováno v:
Phytomedicine Plus, Vol 3, Iss 1, Pp 100400- (2023)
Background: Recent studies have found out that the initiation and progression of cancer, traditionally seen as a genetic disease, is now realized to involve epigenetic abnormalities along with genetic alterations. Studies also emphasize development o
Externí odkaz:
https://doaj.org/article/d29a6cfee2c1415c8370e8175d84bc18
Publikováno v:
Current Research in Immunology, Vol 4, Iss , Pp 100068- (2023)
The immune system has a variety of potential effects on a tumor microenvironment and the course of chemotherapy may vary according to that. Anticancer treatments can encourage the release of unwanted signals from senescent tumor cells or the removal
Externí odkaz:
https://doaj.org/article/ac452cc239654409acb7ea8ce4a63917
Autor:
Rishabh Rai Kaushik, Manvi Koranne, Mamta Sajjansingh Rao, Sudeshna Rakshit, Geetha Shanmugam, Melvin George, Koustav Sarkar
Publikováno v:
Phytomedicine Plus, Vol 2, Iss 4, Pp 100353- (2022)
Background: The most frequent cancers in the world are breast cancer and lung cancer. Regulatory T cells (Treg) are the subtype of T cells that promotes equilibrium between immunological surveillance and immune tolerance, and they are commonly found
Externí odkaz:
https://doaj.org/article/5170083674e94f67ade9fbb56c90488a
Autor:
Ahana Roy, Aitijhya Ghosh, Kasturi Sinha, Basundhara Mitra, Sudeshna Rakshit, Melvin George, Koustav Sarkar
Publikováno v:
Iranian Journal of Immunology, Vol 18, Iss 2, Pp 111-118 (2021)
Background: Breast cancer is an uncontrolled growth of epithelial cells. The loss of BRCA1 activity due to mutation or down-regulation of gene expression promotes tumorigenesis and increases the risk of breast cancer. Objectives: Our aim was to pulsa
Externí odkaz:
https://doaj.org/article/684009948a2b4e4b878af10669ebac62
Publikováno v:
Translational Oncology, Vol 16, Iss , Pp 101312- (2022)
Histone deacetylases (HDACs) are enzymes that play a key role in the epigenetic regulation of gene expression by remodeling chromatin. Inhibition of HDACs is a prospective therapeutic approach for reversing epigenetic alteration in several diseases.
Externí odkaz:
https://doaj.org/article/f6f847d5e13743b2b9f11c6169be8bda
Publikováno v:
Translational Oncology, Vol 14, Iss 10, Pp 101189- (2021)
The effect of epigenetics in coronary artery disease and Non-small cell lung cancer (NSCLC) is presently developing as a significant vital participant at various levels from pathophysiology to therapeutics. We would like to find out the conjunction o
Externí odkaz:
https://doaj.org/article/2f81e580dce7485582ca4fdfcc55e262
Publikováno v:
Clinical Breast Cancer. 23:e95-e102
Autor:
Geetha Shanmugam, Jithin S. Sunny, Sudeshna Rakshit, Melvin George, K.V. Leela, Koustav Sarkar
Publikováno v:
Molecular Immunology. 151:70-83
Dysregulated inflammatory response plays a crucial role in the pathogenesis of chronic obstructive pulmonary disease (COPD) and Non-Small cell lung cancer (NSCLC). Hence, the purpose of this research is to uncover the link between alterations in infl
Autor:
Sudeshna Rakshit, Jithin S. Sunny, Melvin George, Luke Elizabeth Hanna, K. V. Leela, Koustav Sarkar
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:3421-3436
Invasive ductal carcinoma (IDC) and coronary artery disease (CAD), remains the greatest cause of death annually in women, driven by complex signalling pathways and shared several predisposing risk factors together. Therefore, it is important to find
Autor:
Geetha Shanmugam, Nilanjan Paul, Riasha Pal, Deep Bhattacharya, Sudeshna Rakshit, KOUSTAV SARKAR
Publikováno v:
Molecular Biology Reports. 49:10143-10146